GDDDR - Global Drug Design & Development Review

ARTICLE

A REVIEW OF NOVEL TECHNIQUES FOR NANOPARTICLES PREPARATION

http://dx.doi.org/10.31703/gdddr.2019(IV-I).05 10.31703/gdddr.2019(IV-I).05

A Review of Novel Techniques for Nanoparticles Preparation

Abstract

Various types of material are produced by using nanotechnology techniques at nano scale level. Nanoparticle is wide class of nanotechnology having one dimension and particle size less than 100 nm. Nano particles has wide range of application in the field of biomedical because a large number of nano materials such as nano carriers, nanotubes, nanowires and nanorods have been developed. In this review our main focus is to discuss different methods for the preparation of nanoparticles.

Keywords

Nanotechnology, Nanoparticles, Delivery Vehicle, Preparation Techniques

Authors

(1) Irsah Maqbool

(2) Sobia Noreen

Fulltext PDF

References

Agashe, H., Sahoo, K., Lagisetty, P., & Awasthi, V. (2011). Cyclodextrin-mediated entrapment of curcuminoid 4-[3, 5-bis (2-chlorobenzylidene- 4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats. Colloids and Surfaces B: Biointerfaces, 84(2), 329-337.
Allen, T. M. (2002). Ligand-targeted therapeutics in anticancer therapy. Nature Reviews Cancer, 2(10), 750.
Anselmo, A. C., & Mitragotri, S. (2014). Cell- mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles. Journal of controlled release, 190, 531-541.
Attama, A., Reichl, S., & MÃƒÂ¼ller-Goymann, C. (2009). Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea. Current eye research, 34(8), 698-705.
Bhagwat, R., & Vaidhya, I. (2013). Novel drug delivery systems: An overview. International Journal of Pharmaceutical Sciences and Research, 4(3), 970.
Booysen, L., Kalombo, L., Brooks, E., Hansen, R., Gilliland, J., Gruppo, V., . . . Kotze, A. (2013). In vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly- (dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazid. International journal of pharmaceutics, 444(1- 2), 10-17.
Dalpiaz, A., Vighi, E., Pavan, B., & Leo, E. (2009). Fabrication via a nonaqueous nanoprecipitation method, characterization and in vitro biological behavior of N6-cyclopentyladenosine-loaded nanoparticles. Journal of pharmaceutical sciences, 98(11), 4272-4284.
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & PrÃƒÂ©at, V. (2012). PLGA-based nanoparticles: an overview of biomedical applications. Journal of controlled release, 161(2), 505-522.
Douglas, K. L., & Tabrizian, M. (2005). Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. Journal of Biomaterials Science, Polymer Edition, 16(1), 43-56.
El-Nour, K. M. A., Eftaiha, A. a., Al-Warthan, A., & Ammar, R. A. (2010). Synthesis and applications of silver nanoparticles. Arabian journal of chemistry, 3(3), 135-140.
Emeje, M. O., Obidike, I. C., Akpabio, E. I., & Ofoefule, S. I. (2012). Nanotechnology in drug delivery. Recent advances in novel drug carrier systems, 69-106.
Galindo-Rodriguez, S., Allemann, E., Fessi, H., & Doelker, E. (2004). Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification- diffusion, and nanoprecipitation methods. Pharmaceutical research, 21(8), 1428-1439.
Ganachaud, F., & Katz, J. L. (2005). Nanoparticles and nanocapsules created using the Ouzo effect: spontaneous emulsification as an alternative to ultrasonic and high-shear devices. ChemPhysChem, 6(2), 209-216.
Gao, Y., Chen, L., Zhang, Z., Chen, Y., & Li, Y. (2011). Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticles. Biomaterials, 32(6), 1738-1747.
GeÃƒÂ§er, A., YÃ„Â±ldÃ„Â±z, N., ÃƒÂ‡alÃ„Â±mlÃ„Â±, A., & Turan, B. (2010). Trimethyl chitosan nanoparticles enhances dissolution of the poorly water soluble drug Candesartan-Cilexetil. Macromolecular research, 18(10), 986-991.
Greish, K. (2010). Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting Cancer Nanotechnology (pp. 25-37): Springer
Hans, M. L., & Lowman, A. M. (2002). Biodegradable nanoparticles for drug delivery and targeting. Current Opinion in Solid State and Materials Science, 6(4), 319-327.
In, G. K., & Nieva, J. (2015). Emerging chemotherapy agents in lung cancer: nanoparticles therapeutics for non-small cell lung cancer. Translational Cancer Research, 4(4), 340-355.
Iskandar, F., Gradon, L., & Okuyama, K. (2003). Control of the morphology of nanostructured particles prepared by the spray drying of a nanoparticle sol. Journal of Colloid and Interface Science, 265(2), 296-303.
Jain, S., Mittal, A., & K Jain, A. (2011). Enhanced topical delivery of cyclosporin-A using PLGA nanoparticles as carrier. Current nanoscience, 7(4), 524-530.
Jain, S., Mittal, A., K Jain, A., R Mahajan, R., & Singh, D. (2010). Cyclosporin A loaded PLGA nanoparticle: preparation, optimization, in-vitro characterization and stability studies. Current Nanoscience, 6(4), 422-431.
Khan, I., Saeed, K., & Khan, I. (2017). Nanoparticles: Properties, applications and toxicities. Arabian journal of chemistry.
Kim, B., Hwang, S., Park, J., & Park, H. J. (2002). Preparation and characterization of drug- loaded polymethacrylate microspheres by an emulsion solvent evaporation method. Journal of microencapsulation, 19(6), 811-822.
Kostag, M., KÃƒÂ¶hler, S., Liebert, T., & Heinze, T. (2010). Pure cellulose nanoparticles from trimethylsilyl cellulose. Paper presented at the Macromolecular symposia.
Kozek, K. A., Kozek, K. M., Wu, W.-C., Mishra, S. R., & Tracy, J. B. (2013). Large-scale synthesis of gold nanorods through continuous secondary growth. Chemistry of Materials, 25(22), 4537- 4544.
Kreyling, W. G., Semmler, M., & MÃƒÂ¶ller, W. (2004). Dosimetry and toxicology of ultrafine particles. Journal of Aerosol Medicine, 17(2), 140-152.
Kumar, P., Sulochana, P., Nirmala, G., Haridattatreya, M., & Satchidanandam, V. (2004). Conserved amino acids 193-324 of non-structural protein 3 are a dominant source of peptide determinants for CD4 and CD8 T cells in a healthy Japanese encephalitis virus- endemic cohort. Journal of General Virology, 85(5), 1131-1143.
Lamprecht, B., Schider, G., Lechner, R., Ditlbacher, H., Krenn, J. R., Leitner, A., & Aussenegg, F. R. (2000). Metal nanoparticle gratings: influence of dipolar particle interaction on the plasmon resonance. Physical review letters, 84(20), 4721.
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008). Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chemical reviews, 108(6), 2064-2110.
Liu, P. (2013). Modification strategies for carbon nanotubes as a drug delivery system. Industrial & Engineering Chemistry Research, 52(38), 13517-13527.
Liu, Z., Wu, Y., Guo, Z., Liu, Y., Shen, Y., Zhou, P., & Lu, X. (2014). Effects of internalized gold nanoparticles with respect to cytotoxicity and invasion activity in lung cancer cells. PLoS One, 9(6), e99175.
Lu, Z., Bei, J., & Wang, S. (1999). A method for the preparation of polymeric nanocapsules without stabilizer. Journal of Controlled Release, 61(1-2), 107-112.
Marelli, U. K., Rechenmacher, F., Sobahi, T. R. A., Mas-Moruno, C., & Kessler, H. (2013). Tumor targeting via integrin ligands. Frontiers in oncology, 3, 222.
Mishra, B., Patel, B. B., & Tiwari, S. (2010). Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine: Nanotechnology, biology and medicine, 6(1), 9- 24.
Mohanraj, V., & Chen, Y. (2006). Nanoparticles-a review. Tropical journal of pharmaceutical research, 5(1), 561-573.
Morones, J. R., Elechiguerra, J. L., Camacho, A., Holt, K., Kouri, J. B., RamÃƒÂrez, J. T., & Yacaman, M. J. (2005). The bactericidal effect of silver nanoparticles. Nanotechnology, 16(10), 2346.
Mu, L., & Feng, S. (2003). A novel controlled release formulation for the anticancer drug paclitaxel (TaxolÃ‚Â®): PLGA nanoparticles containing vitamin E TPGS. Journal of controlled release, 86(1), 33-48.
Muhamad12, I. I., Selvakumaran, S., & Lazim, N. A. M. (2014). Designing polymeric nanoparticles for targeted drug delivery system. Nanomed, 287, 287.
Nel, A., Xia, T., MÃƒÂ¤dler, L., & Li, N. (2006). Toxic potential of materials at the nanolevel. science, 311(5761), 622-627.
Nicoli, S., Santi, P., Couvreur, P., Couarraze, G., Colombo, P., & Fattal, E. (2001). Design of triptorelin loaded nanospheres for transdermal iontophoretic administration. International journal of pharmaceutics, 214(1-2), 31-35.
Ochekpe, N. A., Olorunfemi, P. O., & Ngwuluka, N. C. (2009). Nanotechnology and drug delivery part 2: nanostructures for drug delivery. Tropical journal of pharmaceutical research, 8(3).
Ouyang, Y., Shi, H., Fu, R., & Wu, D. (2013). Highly monodisperse microporous polymeric and carbonaceous nanospheres with multifunctional properties. Scientific reports, 3, 1430.
Pandey, N., Dhiman, S., Srivastava, T., & Majumder, S. (2016). Transition metal oxide nanoparticles are effective in inhibiting lung cancer cell survival in the hypoxic tumor microenvironment. Chemico-biological interactions, 254, 221-230.
Poland, C. A., Duffin, R., Kinloch, I., Maynard, A., Wallace, W. A., Seaton, A., . . . Donaldson, K. (2008). Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nature nanotechnology, 3(7), 423.
Rangari, A. T., & Ravikumar, P. (2015). Polymeric nanoparticles based topical drug delivery: an overview. Asian Journal of Biomedical and Pharmaceutical Sciences, 5(47), 5.
Rodrigues, S., da Costa, A. M. R., & Grenha, A. (2012). Chitosan/carrageenan nanoparticles: Effect of cross-linking with tripolyphosphate and charge ratios. Carbohydrate polymers, 89(1), 282-289.
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001). Biodegradable polymeric nanoparticles as drug delivery devices. Journal of controlled release, 70(1-2), 1-20.
Stevanovic, M., & Uskokovic, D. (2009). Poly (lactide-co-glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins. Current nanoscience, 5(1), 1-14.
Venkatesh, D. N., Baskaran, M., Karri, V. V. S. R., Mannemala, S. S., Radhakrishna, K., & Goti, S. (2015). Fabrication and in vivo evaluation of Nelfinavir loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic effect. Saudi Pharmaceutical Journal, 23(6), 667-674.
Wang, Y., Wei, X., Zhang, C., Zhang, F., & Liang, W. (2010). Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects. Therapeutic delivery, 1(2), 273- 287.
Xu, Y., Roy, R., Cassaro, G., & Ramsden, J. (2009). Development of a cost estimating framework for nanotechnology based products Global Perspective for Competitive Enterprise, Economy and Ecology (pp. 193-201): Springer.
Yang, W.-W., & Pierstorff, E. (2012). Reservoir- based polymer drug delivery systems. Journal of laboratory automation, 17(1), 50-58.